Abstract
Carmen J. Allegra, MD, assumed the role of editor-in-chief of the Journal of the National Cancer Institute in July. He succeeds Barnett S. Kramer, MD, MPH, who held the position for 18 years.
Allegra is professor and chief of the division of hematology and oncology at the University of Florida, Gainesville, and associate director for clinical and translational research at the University of Florida Shands Cancer Center. In addition, he codirects the Gastrointestinal Cancers Committee of the National Surgical Adjuvant Breast and Bowel Project. [Photo courtesy Jesse Jones/University of Florida]
Mikkael Sekeres, MD, MS, has been named chair of the Oncologic Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA). The committee reviews and evaluates data on the safety and effectiveness of investigational and approved drugs for the treatment of cancer, and makes recommendations to the FDA commissioner. Sekeres has served on the committee for 3 years.
Sekeres directs the leukemia program for the Taussig Cancer Institute at the Cleveland Clinic in Cleveland, OH. [Photo courtesy Cleveland Clinic]
Susan Braun, MBA, began work as the CEO of The V Foundation for Cancer Research in September. The foundation was created in 1993 by ESPN and the late Jim Valvano, legendary North Carolina State basketball coach and sports commentator. Since its inception, the foundation has awarded more than $120 million to cancer researchers.
Most recently, Braun served as executive director at Commonweal. She has also been executive director of the American Society of Clinical Oncology Cancer Foundation and CEO of the Susan G. Komen Breast Cancer Foundation.
For more news on cancer research, visit Cancer Discovery online at http://CDnews.aacrjournals.org.